2015 annual financial data

Viridian Therapeutics 2015 Net margin

Direct answer

Net margin was -446.34%.

Operating income was -11.19M USD and net income was -11.33M USD.
Operating cash flow was -6.9M USD.

Get free Viridian Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
2.54M USD
Operating income
-11.19M USD
Net income
-11.33M USD
Operating cash flow
-6.9M USD